Module 10 questions - Organ failure (Clinical challenge)
  1. Describe the concentration profile for simulation #2 (3.3 mg/kg q8H in terms of efficacy and toxicity).
  2. Describe the concentration profile for simulation #3 (9.9 mg/kg q24H) in terms of efficacy and toxicity.
  3. Describe the concentration profile for simulation #4 (9.9 mg/kg q24H) interms of efficacy and toxicity.
  4. In terms of its pharmacokinetic profile, how is a renal failure patient different from the neonatal patient that you studied in exercise IIe?